Support the news

Lexington Drug Co. Cubist Bought By Merck02:17
Download

Play

The drug giant Merck is making another big acquisition in Massachusetts. It’s buying Cubist Pharmaceuticals in Lexington for $9.5 billion. It’s a sign drug companies are realizing the growing need for new antibiotics to fight so-called "superbugs."

This segment aired on December 8, 2014.

Curt Nickisch Twitter Business & Technology Reporter
Curt Nickisch was formerly WBUR's business and technology reporter.

More…

+Join the discussion
TwitterfacebookEmail

Support the news